Skip to main content

Table 1 Patient characteristics

From: CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis

  Patients (n = 79)
Age (median, range) 59 (44–79)
Gender (male/female) 71/8
Histological grade (1/2/3) 16/57/6
Depth of tumor invasion (Tis/T1/T2/T3) 10/35/7/27
Lymph node metastases (+) 46 (58 %)
Lymphatic invasion (+) 58 (73 %)
Vessel invasion (+) 35 (44 %)
Adjuvant therapy (none/chemotherapy/chemoradiotherapy) 62/16/1
Initial recurrence after surgery (none/lymph node/distant organ/both lymph node and distant organ) 45/14/10/10